Patent ID: 7799773
Filing Date: 2010-09-21
Classification: A61P,C07D

Abstract:
1. A method of treatment of cognitive impairments in Alzheimer's disease, mild cognitive impairment, age-related memory dysfunction, epilepsy, neuropathic pain, Parkinson's disease, cognitive deficit of schizophrenia, attention deficit hyperactivity disorder, or depression, in a human, which comprises administering to said human, an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein: R R X represents a bond or C Y represents a bond, C R n is 0, 1 or 2; and R wherein when R 2 represents —X-heterocyclyl, —X-heterocyclyl-Y—C 3-8 cycloalkyl, —X-heterocyclyl-Y-aryl, —X-heterocyclyl-Y-heteroaryl or —X-heterocyclyl-Y-heterocyclyl, said heterocyclyl group is attached to X via a carbon atom.